![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| COVID-19 |
|
Free Subscription
1 Antiviral Res |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO COVID-19 is free of charge.
SARS-CoV-2 Resistance Analyses From the Phase 3 BIRCH Study of Obeldesivir in
High-Risk Nonhospitalized Participants With COVID-19.
Antiviral Res. 2026 Jan 19:106351. doi: 10.1016/j.antiviral.2026.106351.
PubMed
Abstract available
Help me piece my story together.
BMJ. 2026;392:r2624.
PubMed
Time trends in newly recorded diagnoses of 19 long term conditions before,
during, and after the covid-19 pandemic: population based cohort study in England
using OpenSAFELY.
BMJ. 2026;392:e086393.
PubMed
Abstract available
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2
COVID-19 Vaccines in Adults 18?55 Years Old.
Clin Infect Dis. 2026 Jan 21:ciag026. doi: 10.1093.
PubMed
Abstract available
Functional Limitations and Illness-Related Absenteeism among School-Aged Children
with and without Long COVID, United States, 2022-2023.
Emerg Infect Dis. 2025;31:11-19.
PubMed
Abstract available
Thrombotic Events and Stroke in the Year After COVID-19 or Other Acute
Respiratory Infection.
Emerg Infect Dis. 2025;31:3-10.
PubMed
Abstract available
Long-Term Illness in Adults Hospitalized for Respiratory Syncytial Virus Disease,
United States, February 2022-September 2023.
Emerg Infect Dis. 2025;31:20-29.
PubMed
Abstract available
Progress Toward Understanding Infection-Associated Chronic Conditions and
Illnesses.
Emerg Infect Dis. 2025;31:1-2.
PubMed
Emerging Respiratory Virus Threats from Influenza D and Canine Coronavirus
HuPn-2018.
Emerg Infect Dis. 2026;32.
PubMed
Abstract available
Quantification of airborne respiratory microflora provides insights into airborne
infection risk.
Int J Infect Dis. 2026 Jan 19:108403. doi: 10.1016/j.ijid.2026.108403.
PubMed
Abstract available
Comprehensive analysis of risk factors for Coronavirus disease 2019 infection and
post-infection sequelae based on real-world data from a health insurance database
in Japan.
Int J Infect Dis. 2026 Jan 19:108405. doi: 10.1016/j.ijid.2026.108405.
PubMed
Abstract available
Integrated Genomic and Epidemiological Surveillance to Monitor SARS-CoV-2
Variants in Italy: Insights From the JN.1 Case Study (2023-2024).
J Med Virol. 2026;98:e70775.
PubMed
Abstract available
Establishment of a Point-of-Care Testing Method for Rapid Detection of Multiple
Respiratory Virus Antigens Based on a Dual-Drive Microfluidic Chip.
J Med Virol. 2026;98:e70811.
PubMed
Abstract available
SARS-CoV-2 spike protein expression drives post-acute coagulopathy.
J Virol. 2026 Jan 21:e0125525. doi: 10.1128/jvi.01255.
PubMed
Abstract available
The UK COVID-19 Inquiry and the next pandemic.
Lancet. 2026;407:220-221.
PubMed
AI and nuclear energy feature strongly in agenda-setting technologies for 2026.
Nature. 2026;649:799.
PubMed
Platelet-derived integrin- and tetraspanin-enriched tethers exacerbate severe
inflammation.
Science. 2026;391:eadu2825.
PubMed
Abstract available
Thank you for your interest in scientific medicine.